Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
253 GBX | +1.20% | +28.10% | -17.05% |
May. 03 | Kelso raises stake in NCC; Transense joins project | AN |
Apr. 30 | Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.05% | 228M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.58% | 22.28B | |
-11.90% | 22.41B | |
-4.73% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- FARN Stock
- News Faron Pharmaceuticals Oy
- Faron Pharmaceuticals’ Immunotherapy Candidate Shows Positive Results in Early-stage Trial